Regeneron Pharmaceuticals Inc (WBO:REGN)
€ 910.2 5.8 (0.64%) Market Cap: 99.67 Bil Enterprise Value: 92.44 Bil PE Ratio: 28.90 PB Ratio: 3.99 GF Score: 77/100

Regeneron Pharmaceuticals Inc Annual Shareholders Meeting Transcript

Jun 12, 2020 / 02:30PM GMT
Release Date Price: €533.5 (-1.13%)
Operator

Good morning, and welcome to the 2020 Annual Shareholder Meeting of Regeneron Pharmaceuticals. I am Howard, your operator. At this time, I would like to turn the meeting over to Dr. Roy Vagelos, the Chairman of the Board.

Pindaros Roy Vagelos
Regeneron Pharmaceuticals, Inc. - Chairman of the Board

Good morning, ladies and gentlemen, and welcome. It is 10:30 and time to call the Annual Meeting of Shareholders of Regeneron Pharmaceuticals to order. I'm Roy Vagelos, Chairman of the Board. I would like to welcome you to our first virtual-only annual meeting. We are utilizing this format due to concerns about the COVID-19 pandemic and in an effort to protect the health of our shareholders, employees and other meeting participants. We hope that you, your colleagues and your families remain safe and healthy. We will address Regeneron's efforts regarding COVID-19 shortly. In the event we encounter any technical difficulties that prevent us from continuing the meeting, we ask that you please stand by and allow us time to provide an update regarding the meeting.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot